|
Video: What is a Stock Split?
|
|
Eloxx Pharmaceuticals is a biopharmaceutical company engaged in the science of ribosome modulation, utilizing both its TURBO-ZM chemistry technology platform and its library of aminoglycosides to develop oral small molecule Ribosome Modulating Agents and Eukaryotic Ribosome Selective Glycosides. Co. has various programs in its pipeline including a clinical program for the treatment of Alport syndrome with ELX-02, preclinical programs in investigational new drug (IND) enabling stages in Recessive Dystrophic and Junctional Epidermolysis Bullosa and Familial Adenomatous Polyposis with ZKN-013, and IND enabling stage program with inhaled delivery of ELX-02 in Class 1 cystic fibrosis. According to our ELOX split history records, ELOX has had 1 split. | |
|
ELOX (ELOX) has 1 split in our ELOX split history database. The split for ELOX took place on December 02, 2022. This was a 1 for 40 reverse split, meaning for each 40 shares of ELOX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 25 share position following the split.
When a company such as ELOX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ELOX split history from start to finish, an original position size of 1000 shares would have turned into 25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ELOX shares, starting with a $10,000 purchase of ELOX, presented on a split-history-adjusted basis factoring in the complete ELOX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
10/19/2023 |
|
Start price/share: |
$128.00 |
|
End price/share: |
$1.66 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.70% |
|
Average Annual Total Return: |
-36.71% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$129.70 |
|
Years: |
9.50 |
|
|
|
Date |
Ratio |
12/02/2022 | 1 for 40 |
|
|